DSE:LIBRAINFU

Libra Infusions Limited announcements

229 Dhaka Stock Exchange announcements for Libra Infusions Limited (LIBRAINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2011 (13).

  1. Following the change of denomination, normal trading of the shares of the Company will resume on 04.12.2011 after record

    Following the change of denomination, normal trading of the shares of the Company will resume on 04.12.2011 after record date with new face value of Tk. 10.00 per share, market lot of 200 shares and adjusted open price of Tk. 297.00 per share.

  2. (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2011 (July'11 to Sep'11), the Com

    (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2011 (July'11 to Sep'11), the Company has reported net profit after tax of Tk. 1.96 million with EPS of Tk. 15.66 as against Tk. 2.36 million and Tk. 18.85 respectively for the same period of the previous year.

  3. - Normal trading of the shares...

    Normal trading of the shares of the Company will resume on 13.11.11 after record date for AGM & EGM

  4. Normal trading of the shares of the Company will resume on 13.11.11 after record date for AGM & EGM.

    Normal trading of the shares of the Company will resume on 13.11.11 after record date for AGM & EGM.

  5. Trading of the shares of the Company will remain suspended on record date i.e., 03.11.11 for AGM and EGM.

    Trading of the shares of the Company will remain suspended on record date i.e., 03.11.11 for AGM and EGM.

  6. Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be

    Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 31.10.11 to 02.11.11. Trading of the shares of the Company will remain suspended on record date i.e., 03.11.11 for AGM and EGM.

  7. The Company has further informed that the Record date for AGM of the company will be 03.11.2011 instead of 09.11.2011. O

    The Company has further informed that the Record date for AGM of the company will be 03.11.2011 instead of 09.11.2011. Other information of the AGM as announced earlier.

  8. The Company has informed that in compliance with SEC's Order dated 15.09.2011, the Board of Directors of the Company has

    The Company has informed that in compliance with SEC's Order dated 15.09.2011, the Board of Directors of the Company has decided to change the denomination of face value of shares from Tk. 100.00 to Tk. 10.00 each and market lot from 20 to 200 shares. Date of EGM: 27.11.2011, Time: 11:00 AM, Venue: Corporate Head Office, Building-2 (Level-7) of Libra Infusions Ltd., Plot No. I/7 Mirpur I/E, Rupnagar, Section-2, Dhaka-1216. Record date for EGM: 03.11.2011.

  9. There will be no price limit on the trading of the shares of the Company today (27.10.2011) following its corporate decl

    There will be no price limit on the trading of the shares of the Company today (27.10.2011) following its corporate declaration.

  10. The Board of Directors has recommended cash dividend @ 20% for the year ended on June 30, 2011. Date of AGM: 28.12.2011.

    The Board of Directors has recommended cash dividend @ 20% for the year ended on June 30, 2011. Date of AGM: 28.12.2011. Time: 11:00 AM, Venue: Corporate Head Office, Building-2 (Level-7) of Libra Infusions Ltd., Plot No. I/7 Mirpur I/E, Rupnagar, Section-2, Dhaka-1216. Record Date: 09.11.2011. The Company has also reported Net Profit after Tax of Tk. 7.04 million, NAV of Tk. 1,960.61 million, EPS of Tk. 56.25 and NOCFPS of Tk. (39.09) for the year ended on June 30, 2011.

  11. (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2011 (Jan'11 to March'11), the compan

    (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2011 (Jan'11 to March'11), the company has reported net profit after tax of Tk. 1.13 million with EPS of Tk. 9.01 as against Tk. 0.95 million and Tk. 7.57 respectively for the same period of the previous year. 'Other Income' was Tk. 0.16 million as on 31.03.11 (Jan'11 to March'11) which was Nil as on 31.03.10 (Jan'10 to March'10). Whereas net profit was Tk. 5.53 million with EPS of Tk. 44.16 for the period of nine months (July'10 to March'11) ended on 31.03.2011 as against Tk. 3.62 million and Tk. 28.95 respectively for the same period of the previous year. 'Other Income' was Tk. 2.29 million as on 31.03.11 (July'10 to March'11) which was Nil as on 31.03.10 (July'09 to March'10)

  12. In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the com

    In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.

  13. (H/Y): As per un-audited half yearly accounts as on 31.12.10 (July' 10 to Dec' 10), the company has reported net profit

    (H/Y): As per un-audited half yearly accounts as on 31.12.10 (July' 10 to Dec' 10), the company has reported net profit after tax of Tk. 4.40 million with EPS of Tk. 35.15 as against Tk. 2.68 million and Tk. 21.38 respectively for the same period of the previous year.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.